Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Biraben A, Semah F, Ribeiro MJ, Douaud G, Remy P, Depaulis A. (2004). PET
evidence for a role of the basal ganglia in patients with ring chromosome 20
epilepsy. Neurology, 63: 73–77.
Bitar M, Koulu M, Rapoport SI, Linnoila M. (1986). Diabetes induced alterations
in brain monoamine metabolism in rats. Journal of Pharmacology and
Experimental Therapeutics, 236: 432–437.
Bitner RS, Bunnelle WH, Anderson DJ, Briggs CA, Buccafusco J, Curzon P, Decker
MW, Frost JM, Gronlien JH, Gubbins E, Li J, Malysz J, Markosyan S, Marsh K,
Meyer MD, Nikkel AL, Radek RJ, Robb HM, Timmermann D, Sullivan JP,
Gopalakrishnan M. (2007). Broad–spectrum efficacy across cognitive domains by
alpha7 nicotinic acetylcholine receptor agonism correlates with activation of
ERK1/2 and CREB phosphorylation pathways. J Neurosci, 27: 10578–10587.
Bizzarri C, Girolamo MD, D'Orazio MC. (1990). Evidence that a guanine neucleotide
binding protein linked to a muscarinic receptor inhibits directly phospholipase C.
Proc Natl Acad Sci, 87: 4889–4893.
Blumer D, Montouris G, Davies K. (2004). The interictal dysphoric disorder:
recognition, pathogenesis, and treatment of themajor psychiatric disorder of
epilepsy. Epilepsy Behav, 5: 826–840.
Blusztajn JK, Berse B. (2000). The cholinergic neuronal phenotype in Alzheimer’s
disease. Met. Brain Dis, 15: 45–64.
Bock P. (1986). Fine structure of the neuro–insular complex type II in the cat. Arch
Histol Jpn, 49: 189–197.